What is Wellysis?
Wellysis is a specialized digital healthcare enterprise that emerged from Samsung’s digital health division. The company focuses on the development of sophisticated wearable cardiac monitoring technology. Its flagship ECG monitoring solution is engineered to provide continuous, real-time heart data, offering clinicians and patients actionable insights for the management of cardiovascular health. By combining lightweight, user-friendly hardware with robust data analytics, Wellysis addresses the critical need for accurate, long-term cardiac monitoring outside of traditional clinical settings. This unique value proposition positions the company at the intersection of medical device innovation and digital health, enabling more proactive and personalized patient care.
How much funding has Wellysis raised?
Wellysis has raised a total of $13.5M across 1 funding round:
Other Financing Round
$13.5M
Other Financing Round (2026): $13.5M with participation from Kyobo Life Insurance, Koloninvestment, Korea Investment Partners, SBI Investment Korea, Samsung Securities, and Kyobo Securities
Key Investors in Wellysis
SBI Investment Korea
A Seoul-based venture capital and private equity firm with a broad mandate, specializing in growth-stage investments across the biotechnology, healthcare, and high-technology sectors.
Samsung Securities
A premier Korean financial institution providing comprehensive corporate finance, brokerage, and investment advisory services with a strong global market presence.
Kyobo Securities
A specialized financial services provider offering asset management and investment advisory services, focusing on innovative solutions for institutional and individual clients.
What's next for Wellysis?
With the successful closure of this major strategic investment, Wellysis is poised to enter a phase of aggressive market expansion and product refinement. The company is expected to utilize these funds to enhance its proprietary ECG analysis algorithms and scale its manufacturing capabilities to meet the growing global demand for remote cardiac monitoring solutions. Furthermore, the strategic involvement of its diverse investor base suggests a focus on strengthening its clinical partnerships and navigating the complex regulatory landscapes of international healthcare markets. As Wellysis continues to iterate on its wearable technology, the firm is likely to prioritize the integration of its data-driven insights into broader hospital information systems, thereby solidifying its role as an essential component of the modern digital health ecosystem.
See full Wellysis company page
